相关实验视频
Updated: Sep 13, 2025

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.6K
克洛沙平和监管惯性:重新审视证据,风险和改革
1Department of Internal Medicine, Dermatology and Psychiatry and Instituto Universitario de Neurociencia (IUNE), Universidad de La Laguna, 38200 La Laguna, Spain.
Healthcare (Basel, Switzerland)
|July 29, 2025
概括
美国克洛扎风险评估和缓解战略 (REMS) 计划为克洛扎,治疗耐药精神分裂症的最有效治疗方法,创造了进入障碍. 需要进行改革,使法规与科学证据和全球实践保持一致.
科学领域:
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
- 监管科学 监管科学
背景情况:
- 克洛扎宾在治疗耐药精神分裂症 (TRS) 中具有高度有效性.
- 美国的克洛扎风险评估和缓解战略 (REMS) 计划造成了行政负担,阻碍了患者的访问.
- 过时的法规,文化因素和临床犹限制了克洛扎的使用,尽管它是有效的.
研究的目的:
- 重新评估克洛扎的药理动力学基础和安全性.
- 批评现有的美国REMS计划,并倡导监管改革.
- 提出改变,使美国的做法与国际标准和当前的科学证据保持一致.
主要方法:
- 对药物动力学数据和与不良结果的历史关联的审查.
- 分析美国REMS计划的结构和对访问的影响.
- 综合国际专家共识和全球克洛扎处方实践.
主要成果:
- 美国REMS计划的复杂性为克洛扎平的获取带来了重大障碍.
- 证据表明监管保守主义,而不是科学数据,延续了这些障碍.
- 国际实践和专家共识支持现代化的监测和处方指南.
结论:
- 美国REMS计划需要实质性改革,以改善克洛扎的可访问性.
- 将美国法规与当代科学和全球标准相协调至关重要.
- 拆除REMS计划是实现克洛扎宾在TRS患者中充分发挥临床潜力的一步.
相关概念视频
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Drug Therapy
100
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
100
Psychosurgery
106
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
106
Psychosis and Antipsychotic Drugs: Overview
458
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
458
Psychological and Sociocultural Causes of Schizophrenia
189
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
189
Drug Control Governance: Regulatory Bodies and Their Impact
250
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
250

